Procedural Codes/J7665

J7665 HCPCS 2026 Code: Mannitol, administered through an inhaler, 5 mg

J7665 is the authoritative medical code for Mannitol, administered through an inhaler, 5 mg. This classification is used in medical billing and clinical recording to specify the clinical criteria for mannitol, administered through an inhaler, 5 mg (HCPCS Level II J7665), ensuring healthcare documentation aligns with 2026 federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Official Registry Overview & Definition

Mannitol, administered through an inhaler, 5 mg is a HCPCS Level II code J7665 for a Medicare-covered supply, service, or procedure. Short description: Mannitol for inhaler.

Codes in This Family (40)

Official HCPCS Level II classifications in the same code family as J7665, with their registry titles.

  • J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
  • J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
  • J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
  • J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
  • J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
  • J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
  • J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
  • J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
  • J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
  • J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
  • J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
  • J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
  • J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
  • J7620 — Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
  • J7622 — Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7624 — Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7626 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
  • J7627 — Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
  • J7628 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7629 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7631 — Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
  • J7632 — Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
  • J7633 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
  • J7634 — Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
  • J7635 — Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7636 — Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7637 — Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7638 — Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7639 — Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7640 — Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
  • J7641 — Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
  • J7642 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7643 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7644 — Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7645 — Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7647 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7648 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
  • J7649 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7650 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7657 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

Related Codes & Numerical Sequence (Crawl Map)

Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:

HCPCS Code J7660 Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS Code J7661 Drugs Administered Other than Oral Method
HCPCS Code J7662 Drugs Administered Other than Oral Method
HCPCS Code J7663 Drugs Administered Other than Oral Method
HCPCS Code J7664 Drugs Administered Other than Oral Method
HCPCS Code J7666 Drugs Administered Other than Oral Method
HCPCS Code J7667 Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
HCPCS Code J7668 Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
HCPCS Code J7669 Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
HCPCS Code J7670 Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
MedCoder.aiClinical Desktop